108 related articles for article (PubMed ID: 16579694)
1. A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vivo.
Lee DY; Park SJ; Nam JH; Byun Y
Tissue Eng; 2006 Mar; 12(3):615-23. PubMed ID: 16579694
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of surface modification with poly(ethylene glycol) and immunosuppressants on repetitive pancreatic islet transplantation into antecedently sensitized rat.
Jeong JH; Yook S; Hwang JW; Jung MJ; Moon HT; Lee DY; Byun Y
Transplant Proc; 2013 Mar; 45(2):585-90. PubMed ID: 23267798
[TBL] [Abstract][Full Text] [Related]
3. A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation.
Lee DY; Park SJ; Nam JH; Byun Y
J Control Release; 2006 Jan; 110(2):290-295. PubMed ID: 16324765
[TBL] [Abstract][Full Text] [Related]
4. Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication.
Lee DY; Park SJ; Lee S; Nam JH; Byun Y
Tissue Eng; 2007 Aug; 13(8):2133-41. PubMed ID: 17516853
[TBL] [Abstract][Full Text] [Related]
5. Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year.
Yun Lee D; Hee Nam J; Byun Y
Biomaterials; 2007 Apr; 28(11):1957-66. PubMed ID: 17188350
[TBL] [Abstract][Full Text] [Related]
6. Cell surface modification by activated polyethylene glycol prevents allosensitization after islet transplantation.
Wee YM; Lim DG; Kim YH; Kim JH; Kim SC; Yu E; Park MO; Choi MY; Park YH; Jang HJ; Cho EY; Cho MH; Han DJ
Cell Transplant; 2008; 17(10-11):1257-69. PubMed ID: 19181219
[TBL] [Abstract][Full Text] [Related]
7. Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet.
Lee DY; Lee S; Nam JH; Byun Y
Am J Transplant; 2006 Aug; 6(8):1820-8. PubMed ID: 16780547
[TBL] [Abstract][Full Text] [Related]
8. Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets.
Izadi Z; Hajizadeh-Saffar E; Hadjati J; Habibi-Anbouhi M; Ghanian MH; Sadeghi-Abandansari H; Ashtiani MK; Samsonchi Z; Raoufi M; Moazenchi M; Izadi M; Nejad ASSH; Namdari H; Tahamtani Y; Ostad SN; Akbari-Javar H; Baharvand H
Biomaterials; 2018 Nov; 182():191-201. PubMed ID: 30134210
[TBL] [Abstract][Full Text] [Related]
9. Combination strategy of multi-layered surface camouflage using hyperbranched polyethylene glycol and immunosuppressive drugs for the prevention of immune reactions against transplanted porcine islets.
Haque MR; Jeong JH; Byun Y
Biomaterials; 2016 Apr; 84():144-156. PubMed ID: 26828680
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of PEG-dendron for surface modification of pancreatic islets and suppression of the immune response.
Jeon SI; Jeong JH; Kim JE; Haque MR; Kim J; Byun Y; Ahn CH
J Mater Chem B; 2021 Mar; 9(11):2631-2640. PubMed ID: 33683280
[TBL] [Abstract][Full Text] [Related]
11. Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation.
Jeong JH; Hong SW; Hong S; Yook S; Jung Y; Park JB; Khue CD; Im BH; Seo J; Lee H; Ahn CH; Lee DY; Byun Y
Biomaterials; 2011 Nov; 32(31):7961-70. PubMed ID: 21831422
[TBL] [Abstract][Full Text] [Related]
12. Benefits of PEGylation in the early post-transplant period of intraportal islet transplantation as assessed by magnetic resonance imaging of labeled islets.
Jin SM; Oh SH; Oh BJ; Suh S; Bae JC; Lee JH; Lee MS; Lee MK; Kim KW; Kim JH
Islets; 2014; 6(1):e27827. PubMed ID: 25483878
[TBL] [Abstract][Full Text] [Related]
13. The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets.
Im BH; Jeong JH; Haque MR; Lee DY; Ahn CH; Kim JE; Byun Y
Biomaterials; 2013 Mar; 34(8):2098-106. PubMed ID: 23261215
[TBL] [Abstract][Full Text] [Related]
14. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
Jeong JH; Yook S; Lee H; Ahn CH; Lee DY; Byun Y
Biochem Biophys Res Commun; 2013 Apr; 433(4):513-8. PubMed ID: 23523788
[TBL] [Abstract][Full Text] [Related]
15. Cell Surface Engineering for Regulation of Immune Reactions in Cell Therapy.
Teramura Y; Asif S; Ekdahl KN; Nilsson B
Adv Exp Med Biol; 2015; 865():189-209. PubMed ID: 26306451
[TBL] [Abstract][Full Text] [Related]
16. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs.
Morsiani E; Fogli L; Lanza G; Lebow LT; Demetriou AA; Rozga J
Cell Transplant; 2002; 11(1):55-66. PubMed ID: 12095221
[TBL] [Abstract][Full Text] [Related]
17. Effect of molecular mass of methoxypoly(ethylene glycol) activated with succinimidyl carbonate on camouflaging pancreatic islets.
Barani L; Vasheghani-Farahani E; Lazarjani HA; Hashemi-Najafabadi S; Atyabi F
Biotechnol Appl Biochem; 2010 Sep; 57(1):25-30. PubMed ID: 20731621
[TBL] [Abstract][Full Text] [Related]
18. Xenotransplantation of layer-by-layer encapsulated non-human primate islets with a specified immunosuppressive drug protocol.
Haque MR; Kim J; Park H; Lee HS; Lee KW; Al-Hilal TA; Jeong JH; Ahn CH; Lee DS; Kim SJ; Byun Y
J Control Release; 2017 Jul; 258():10-21. PubMed ID: 28433740
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation.
Xie D; Smyth CA; Eckstein C; Bilbao G; Mays J; Eckhoff DE; Contreras JL
Biomaterials; 2005 Feb; 26(4):403-12. PubMed ID: 15275814
[TBL] [Abstract][Full Text] [Related]
20. The synergistic effect of Tautomycetin on Cyclosporine A-mediated immunosuppression in a rodent islet allograft model.
Wee YM; Choi MY; Kang CH; Kim YH; Kim JH; Lee SK; Yu SY; Kim SC; Han DJ
Mol Med; 2010; 16(7-8):298-306. PubMed ID: 20440443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
